GSTM1 and cancer: Furthermore, the incidence of non-gastrointestinal cancer in the subgroup of patients with CEA below the threshold 3 ng/mL and FIT < 20 μg Hb/g feces exceed the threshold risk of cancer of 3% recommended by the 2015 version of the NICE guidelines for investigation [29].